A clinical case of multilocus imprinting disturbances: the first description in the Russian Federation

   Multilocus imprinting disturbances (MLID) is a molecular subtype of imprinting disorders (IDs), in which multiple methylation abnormalities of imprinted regions and genes are observed in combination with polymorphic clinical manifestations, including overlapping phenotypic features of individual imprinting disorders. The causes of MLID are mutations in genes encoding oocyte and zygotic factors of embryo development, which increases the risk of recurrent birth of children with imprinting disorders in mothers carrying such mutations. Due to the need to understand the exact risk for repeated childbirth, it is advisable to diagnose MLID in patients with an ambiguous phenotype and a negative result of studies on individual imprinting disorders, followed by a search for mutations in MLID-associated genes.

   The purpose of the work is to describe the clinical and epigenetic characteristics of a patient with MLID.

   A clinical case of a comorbid patient aged 12 years with an established molecular genetic diagnosis of MLID by the method of methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) is presented. The features of the patient’s phenotype allow us to demonstrate the effect of hypomethylation of several differentially methylated regions of imprinted genes on the formation of a polymorphic phenotype, including overlapping signs of individual imprinting disorders, and to assess the difficulty of making an unambiguous clinical diagnosis for this patient. Pronounced clinical polymorphism, negative results of previously conducted molecular genetic studies on certain forms of imprinting disorders allow us to consider the MLID study as a first-line test for the diagnosis of methylation abnormalities in MLID and imprinting disorders.

1. Zaletaev D.V., Nemtsova M.V., Strelnikov V.V. Disorders of epigenetic regulation of gene expression in imprinting diseases. Molekulyarnaya biologiya 2022; 56(1): 3–34. (in Russ.) DOI: 10.31857/S0026898421060148

2. Elbracht M., Mackay D., Begemann M., Kagan K.O., Eggermann T. Disturbed genomic imprinting and its relevance for human reproduction: causes and clinical consequences. Hum Reprod Update 2020; 26(2): 197–213. DOI: 10.1093/humupd/dmz045

3. Eggermann T. Human Reproduction and Disturbed Genomic Imprinting. Genes (Basel) 2024; 15(2): 163. DOI: 10.3390/genes15020163

4. Javadi A., Shamaei M., Mohammadi Ziazi L., Pourabdollah M., Dorudinia A., Seyedmehdi S.M., Karimi S. Qualification study of two genomic DNA extraction methods in different clinical samples. Tanaffos 2014; 13(4): 41–47.

5. Elbracht M., Binder G., Hiort O., Kiewert C., Kratz C., Eggermann T. Clinical spectrum and management of imprinting disorders. Medizinische Genetik 2020; 32(4): 321–334. DOI: 10.1515/medgen-2020–2044

6. Wakeling E.L., Brioude F., Lokulo-Sodipe O., O’Connell S.M., Salem J., Bliek J. et al. Diagnosis and management of Silver-Russell syndrome: first international consensus statement. Nat Rev Endocrinol 2017; 13(2): 105–124. DOI: 10.1038/nrendo.2016.138

7. Hokken-Koelega A.C., van der Steen M., Boguszewski M.C., Cianfarani S., Dahlgren J., Horikawa R. et al. International consensus guideline on small for gestational age: etiology and management from infancy to early adulthood. Endocrine Rev 2023; 44(3): 539–565. DOI: 10.1210/endrev/bnad002

8. Ioannides Y., Lokulo-Sodipe K., Mackay D.J., Davies J.H., Temple I.K. Temple syndrome: improving the recognition of an underdiagnosed chromosome 14 imprinting disorder: an analysis of 51 published cases. J Med Genet 2014; 51(8): 495–501. DOI: 10.1136/jmedgenet-2014–102396

9. Prasasya R., Grotheer K., Siracusa L., Bartolomei M. Temple syndrome and Kagami-Ogata syndrome: clinical presentations, genotypes, models and mechanisms. Hum Mol Genet 2020; 29(R1): R107–R116. DOI: 10.1093/hmg/ddaa133

10. Gillessen-Kaesbach G., Albrecht B., Eggermann T., Elbracht M., Mitter D., Morlot S. et al. Molecular and clinical studies in 8 patients with Temple syndrome. Clin Genet 2018; 93(6): 1179–1188. DOI: 10.1111/cge.13244

11. Greeley S.A.W., Polak M., Njølstad P.R., Barbetti F., Williams R., Castano L. et al. ISPAD Clinical Practice Consensus Guidelines 2022: The diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diab 2022; 23(8): 1188–1211. DOI: 10.1111/pedi.13426

12. Williams C.A., Beaudet A.L., Clayton-Smith J., Knoll J.H., Kyllerman M., Laan L.A. et al. Angelman syndrome 2005: updated consensus for diagnostic criteria. Am J Med Genet A 2006; 140(5): 413–418. DOI: 10.1002/ajmg.a.31074

13. Eggermann T., Yapici E., Bliek J., Pereda A., Begemann M., Russo S. et al. Trans-acting genetic variants causing multilocus imprinting disturbance (MLID): common mechanisms and consequences. Clin Epigenet 2022; 14: 41. DOI: 10.1186/s13148–022–01259-x